[ET Net News Agency, 6 February 2024] HANSOH PHARMA (03692) rose 10.1% to HK$12.86,
breaking above the 20-D SMA of HK$12.484.
It hits an intra-day high of HK$12.86, and an intra-day low of HK$11.62. The total
shares traded was 7.03 million, with a value of HK$87.56m. The active buy/sell ratio is
52:48, with net buying turnover of HK$3.9m. GOLDMAN SACHS (ASIA) SEC accounts for greatest
net responsive buying turnover of HK$6.23m, with volume weighted average price of
HK$12.483. MORGAN STANLEY HK SEC accounts for greatest net responsive selling turnover of
HK$9.43m, with volume weighted average price of HK$12.421. The stock has risen a combined
13% over the past 2 consecutive trading days.
The Hang Seng Index now rose 597 points, or 3.9% to 16,107.

Basic Information
=================

----------------------------------
Nominal 12.860 % Chg +10.10%
High 12.860 Low 11.620
Shares Tr 7.03m Turnover 87.56m
10-D SMA 12.044 %H.V 48.458
20-D SMA 12.484 VWAP 12.448
50-D SMA 13.906 RSI14 50.643
----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 52:48, with net buying
turnover of HK$3.9m, rising a combined 13% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 12.86 +10.10
ALI HEALTH (00241) 3.00 +6.76
TRAD CHI MED (00570) 3.08 +5.84
CSPC PHARMA (01093) 6.18 +7.48
SINOPHARM (01099) 21.45 +4.38
SINO BIOPHARM (01177) 2.97 +6.83
CHINARES PHARMA (03320) 5.09 +8.99
SCICLONE PHARMA (06600) 11.44 +4.38
JD HEALTH (06618) 28.05 +6.86
GOLDEN THROAT (06896) 3.58 -0.56
-----------------------------------------------
(ed)